Recurrent ocular toxoplasmosis is associated with interferon-gamma deficiency possibly due to genetic origin.


Journal

BMJ open ophthalmology
ISSN: 2397-3269
Titre abrégé: BMJ Open Ophthalmol
Pays: England
ID NLM: 101714806

Informations de publication

Date de publication:
13 Sep 2024
Historique:
received: 11 05 2024
accepted: 30 08 2024
medline: 15 9 2024
pubmed: 15 9 2024
entrez: 14 9 2024
Statut: epublish

Résumé

Ocular toxoplasmosis (OT) can cause posterior uveitis; causes of recurrent OT are not well understood. We explored clinical, immunological and genetic properties associated with recurrent OT. A recurrent OT patient population (n=9) was identified. Clinical history, ophthalmological findings and immunological properties were assessed. B and T cell immunophenotyping including interferon-gamma (IFN-γ) responses were analysed. An analysis of 592 immunodeficiency genes was performed. The patients experienced 2-7 OT episodes (average 3.7). The first episode occurred at an average of 23.8 (SD 10.1) years of age. All patients had anterior uveitis, vitritis and various fundus lesions of OT. The patients had lymphocyte maturation abnormalities; the proportion of naive CD4 Our recurrent OT cases had deviations in lymphocyte maturation and IFN-γ responses possibly caused by genetic reasons. However, limitations of our study include failure to identify uniform genetic mechanisms. In addition, we cannot rule out the possibility that the immunological abnormalities can be triggered by chronic toxoplasmosis. Despite the limitations, our findings contribute to the understanding of ocular immunity and development of recurrent OT.

Identifiants

pubmed: 39277179
pii: bmjophth-2024-001769
doi: 10.1136/bmjophth-2024-001769
pii:
doi:

Substances chimiques

Interferon-gamma 82115-62-6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Nina Maria Hautala (NM)

Research Unit of Clinical Medicine, Department of Ophthalmology, University of Oulu, Oulu, Finland.
Department of Ophthalmology, Medical Research Center, Oulu University Hospital, Oulu, Finland.

Maija Joensuu (M)

Northern Finland Laboratory Center Nordlab, NordLab Laboratoriot, Oulu, Finland.

Teija Paakkola (T)

Northern Finland Laboratory Center Nordlab, NordLab Laboratoriot, Oulu, Finland.

Virpi Glumoff (V)

Research Unit of Internal Medicine and Biomedicine, University of Oulu, Oulu, Finland.

Kaisa Kettunen (K)

HUS Diagnostic Center, Division of Genetics and Clinical Pharmacology, Laboratory of Genetics, HUS Helsinki University Hospital, Helsinki, Finland.
HiLIFE, Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland.

Janna Saarela (J)

HiLIFE, Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland.
Centre for Molecular Medicine, University of Oslo, Oslo, Norway.

Mira Siiskonen (M)

Department of Ophthalmology, Oulu University Hospital, Oulu, Finland.
University of Oulu, Oulu, Finland.

Zhi Chen (Z)

Faculty of Biochemistry and Molecular Medicine, University of Oulu, Oulu, Finland.

Katri Pylkäs (K)

Northern Finland Laboratory Center Nordlab, NordLab Laboratoriot, Oulu, Finland.
Research Unit of Translational Medicine, University of Oulu, Oulu, Finland.

Timo Hautala (T)

Research Unit of Internal Medicine and Biomedicine, University of Oulu, Oulu, Finland timo.hautala@oulu.fi.
ERN-RITA Core Center Member, RITAFIN Consortium, Infectious Diseases Clinic, Oulu University Hospital, Oulu, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH